Patents by Inventor Michael Maiwald

Michael Maiwald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8198452
    Abstract: The invention relates to a process for the manufacture of enantiomerically enriched or pure compounds of formula I wherein R1, R2, R3, R6, R7 and Q are defined as in claim 1 as well as their crystalline forms for the treatment of proliferative diseases such as cancer.
    Type: Grant
    Filed: May 26, 2007
    Date of Patent: June 12, 2012
    Assignee: Merck Patent Gesellschaft MIT Beschränkter Haftung
    Inventors: Kai Schiemann, Ulrich Emde, Tobias Schlueter, Christoph Saal, Michael Maiwald
  • Publication number: 20090176820
    Abstract: The invention relates to a process for the manufacture of enantiomerically enriched or pure compounds of formula I wherein R1, R2, R3, R6, R7 and Q are defined as in claim 1 as well as their crystalline forms for the treatment of proliferative diseases such as cancer.
    Type: Application
    Filed: May 26, 2007
    Publication date: July 9, 2009
    Inventors: Kai Schiemann, Ulrich Emde, Tobias Schlueter, Christoph Saal, Michael Maiwald